Differential Characteristics of Ketamine Self-Administration in the Olfactory Bulbectomy Model of Depression in Male Rats

被引:20
作者
Babinska, Zuzana [1 ]
Ruda-Kucerova, Jana [1 ]
机构
[1] Masaryk Univ, Dept Pharmacol, Fac Med, Kamenice 5, Brno 62500, Czech Republic
关键词
ketamine; self-administration; olfactory bulbectomy; depression; Wistar rats; DEEP BRAIN-STIMULATION; NEUROTROPHIC FACTOR; METHAMPHETAMINE SEEKING; NEUROCOGNITIVE FUNCTION; MEDICATION HYPOTHESIS; PREFRONTAL CORTEX; FORCED ABSTINENCE; DOPAMINE RELEASE; FEMALE RATS; ANTIDEPRESSANT;
D O I
10.1037/pha0000106
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Ketamine has been extensively studied for its antidepressant potential, with promising results in both preclinical and clinical studies. However, concerns regarding its abuse liabilities greatly limit its potential to become an approved treatment for depression. Therefore, a better understanding the risks and benefits of ketamine use in depression is needed. This study aimed to assess the characteristics of operant intravenous (IV) ketamine self-administration and relapse-like behavior in the olfactory bulbectomy (OBX) model of depression in male rats. Twenty-five male Wistar rats were divided randomly into 2 groups; in 1 group the bilateral olfactory bulbectomy was performed, whereas the other group was sham-operated. Intravenous self-administration of ketamine (.5 mg/kg/infusion) was conducted under a fixed ratio 1 schedule of reinforcement. After reaching stable drug intakes, rats then underwent a 14-day period of forced abstinence followed by a drug-free relapse-like session. The forced swim test was conducted before the commencement of the self-administration protocol and on the 1st day of abstinence. Consistent with findings in previous studies on other substances, OBX animals showed increased operant IV ketamine self-administration. In contrast, ketamine-seeking behavior in the OBX group did not differ from sham-operated animals during the relapse-like session, whereas previous studies on other psychostimulants like methamphetamine and cocaine reported increases. Our findings suggest substantially different underlying neuroadaptations between chronic ketamine and psychostimulant exposure.
引用
收藏
页码:84 / 93
页数:10
相关论文
共 68 条
  • [1] Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR
    Akinfiresoye, Luli
    Tizabi, Yousef
    [J]. PSYCHOPHARMACOLOGY, 2013, 230 (02) : 291 - 298
  • [2] Enhanced self-administration of the CBI receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms
    Amchova, Petra
    Kucerova, Jana
    Giugliano, Valentina
    Babinska, Zuzana
    Zanda, Mary T.
    Scherma, Maria
    Dusek, Ladislav
    Fadda, Paola
    Micale, Vincenzo
    Sulcova, Alexandra
    Fratta, Walter
    Fattore, Liana
    [J]. FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [3] Should ketamine be used for the clinical treatment of depression?
    Arunogiri, Shalini
    Keks, Nicholas A.
    Hope, Judy
    [J]. AUSTRALASIAN PSYCHIATRY, 2016, 24 (04) : 381 - 384
  • [4] Olfactory bulbectomy increases reinstatement of methamphetamine seeking after a forced abstinence in rats
    Babinska, Zuzana
    Ruda-Kucerova, Jana
    Amchova, Petra
    Merhautova, Jana
    Dusek, Ladislav
    Sulcova, Alexandra
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2016, 297 : 20 - 27
  • [5] Bokor Gyula, 2014, J Pharm Pract, V27, P582, DOI 10.1177/0897190014525754
  • [6] Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction
    Bonnet, Udo
    [J]. JOURNAL OF PSYCHOACTIVE DRUGS, 2015, 47 (04) : 276 - 285
  • [7] Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
    Browne, Caroline A.
    Lucki, Irwin
    [J]. FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [8] The modulation of BDNF expression and signalling dissects the antidepressant from the reinforcing properties of ketamine: Effects of single infusion vs. chronic self-administration in rats
    Caffino, Lucia
    Di Chio, Marzia
    Giannotti, Giuseppe
    Venniro, Marco
    Mutti, Anna
    Padovani, Laura
    Cheung, David
    Fumagalli, Guido F.
    Yew, David T.
    Fumagalli, Fabio
    Chiamulera, Cristiano
    [J]. PHARMACOLOGICAL RESEARCH, 2016, 104 : 22 - 30
  • [9] Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
    Can, Adem
    Zanos, Panos
    Moaddel, Ruin
    Kang, Hye Jin
    Dossou, Katinia S. S.
    Wainer, Irving W.
    Cheer, Joseph F.
    Frost, Douglas O.
    Huang, Xi-Ping
    Gould, Todd D.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 359 (01) : 159 - 170
  • [10] The role of setting for ketamine abuse: clinical and preclinical evidence
    De Luca, Maria Teresa
    Meringolo, Maria
    Spagnolo, Primavera Alessandra
    Badiani, Aldo
    [J]. REVIEWS IN THE NEUROSCIENCES, 2012, 23 (5-6) : 769 - 780